August 22, 2022
A California executive compensation expert told a Manhattan federal judge that he made illegal bets on a pharmaceutical sector client company that had been targeted for acquisition by global giant Sanofi SA, copping to insider trading charges.
May 24, 2022
A California executive compensation consultant has been charged with insider trading for bets he made on a biopharmaceutical client right before it was acquired by Sanofi SA, federal prosecutors in New York announced Tuesday.